home / stock / artl / artl quote
Last: | $ |
---|---|
Change Percent: | 2.11% |
Open: | $1.58 |
Close: | $1.45 |
High: | $1.58 |
Low: | $1.45 |
Volume: | 48,173 |
Last Trade Date Time: | 02/12/2020 04:34:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $1.58 | $1.45 | $1.58 | $1.45 | 48,173 | 02-12-2020 |
$ | $1.52 | $1.42 | $1.70 | $1.25 | 133,505 | 02-11-2020 |
$ | $2.06 | $1.71 | $2.06 | $1.65 | 111,940 | 02-10-2020 |
$ | $2.01 | $2.02 | $2.0899 | $2.00 | 56,605 | 02-07-2020 |
$ | $2.21 | $2.05 | $2.21 | $2.01 | 95,474 | 02-06-2020 |
$ | $2.21 | $2.14 | $2.2103 | $2.06 | 121,665 | 02-05-2020 |
$ | $2.65 | $2.20 | $2.65 | $2.16 | 467,829 | 02-04-2020 |
$ | $3.37 | $2.75 | $4.4234 | $2.50 | 10,028,194 | 02-03-2020 |
$ | $2.07 | $2.0522 | $2.1331 | $2.04 | 17,397 | 01-31-2020 |
$ | $2.0862 | $2.1541 | $2.2679 | $2.0746 | 8,788 | 01-30-2020 |
$ | $2.18 | $2.11 | $2.20 | $2.10 | 7,742 | 01-29-2020 |
$ | $2.2371 | $2.1711 | $2.2371 | $2.1441 | 9,881 | 01-28-2020 |
$ | $2.23 | $2.19 | $2.2394 | $2.1623 | 28,997 | 01-27-2020 |
$ | $2.2523 | $2.29 | $2.4999 | $2.25 | 85,654 | 01-24-2020 |
$ | $2.42 | $2.30 | $2.4693 | $2.2582 | 29,355 | 01-23-2020 |
$ | $2.38 | $2.42 | $2.4621 | $2.3525 | 19,847 | 01-22-2020 |
$ | $2.30 | $2.40 | $2.49 | $2.30 | 42,353 | 01-21-2020 |
$ | $2.34 | $2.3495 | $2.55 | $2.26 | 158,491 | 01-20-2020 |
$ | $2.34 | $2.3495 | $2.55 | $2.26 | 158,391 | 01-17-2020 |
$ | $2.32 | $2.3489 | $2.3788 | $2.26 | 38,001 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Artelo Biosciences Inc. Company Name:
ARTL Stock Symbol:
OTCMKTS Market:
Artelo Biosciences Inc. Website:
SOLANA BEACH, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological, and neurological co...
SOLANA BEACH, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focu...
SOLANA BEACH, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological condi...